SUSAN LANSBURY: Open Payments
NPI 1619043908 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 22 payments from 10 companies in 2025. Trend: 2023 $517 · 2024 $952 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $72 |
| Collegium Pharmaceutical, Inc. | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Lundbeck LLC | 3 | $55 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Tris Pharma Inc | 1 | $14 |
Products named: REXULTI, VRAYLAR, Jornay PM, FANAPT, INGREZZA, Qelbree, AUSTEDO XR, CAPLYTA.
Industry payments across VA — which companies pay providers there.
